Skip to main content
. Author manuscript; available in PMC: 2007 Mar 9.
Published in final edited form as: Endocrinology. 2006 Aug 24;147(12):5592–5599. doi: 10.1210/en.2006-0459

TABLE 1.

Expression of the TRAP-11β-HSD2 transgene does not alter basal bone geometry, mineral density, or vertebral cancellous histomorphometry in 6.5-month-old mice

Measurement Wild-type (n = 8) Transgenic (n = 7)
Geometry
 Weight (g) 32.2 ± 4.3 35.1 ± 3.4
 Vertebral height (mm) 3.4 ± 0.1 3.4 ± 0.1
 Vertebral depth (mm) 1.3 ± 0.1 1.4 ± 0.1
 Vertebral width (mm) 2.1 ± 0.4 2.3 ± 0.2
BMD (mg/mm2) 61.1 ± 3.1 62.4 ± 4.6
Histomorphometry
 Bone area (%) 13.1 ± 3.3 13.4 ± 1.8
 Trabecular width (μm) 35.2 ± 4.6 35.6 ± 2.8
 Trabecular spacing (μm) 241.9 ± 41.2 233.5 ± 29.0
 Trabecular number (/mm) 3.7 ± 0.5 3.8 ± 0.4
 Wall width (μm) 7.3 ± 0.6 6.8 ± 1.2
 Osteoid area (%) 1.6 ± 0.7 1.9 ± 0.8
 Osteoid width (μm) 2.4 ± 0.2 2.5 ± 0.2
 Osteoblast number (mm) 6.6 ± 1.9 7.2 ± 1.8
 Osteoclast number (mm) 1.9 ± 0.3 1.7 ± 0.7

Values are given as mean ± SD of measurements.